Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:FWP Forward Pharma A/S (FWP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Forward Pharma A/S Stock (NASDAQ:FWP) 30 days 90 days 365 days Advanced Chart Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Forward Pharma A/S alerts:Sign Up Key Stats Today's Range$1.95▼$1.9550-Day Range$1.79▼$3.1952-Week Range$1.50▼$6.48VolumeN/AAverage Volume7,484 shsMarket Capitalization$13.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewForward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.Read More… 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Receive FWP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address FWP Stock News HeadlinesInside Forward's failed attempt to revolutionize the doctor's officeNovember 14, 2024 | businessinsider.comU.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain PartnersNovember 1, 2024 | msn.comTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.November 21, 2024 | Weiss Ratings (Ad)Sangamo: Fabry Disease Gene Therapy Moves Forward With Positive FDA Regulatory DevelopmentOctober 23, 2024 | seekingalpha.comWhy developers are turning to Forward Factory’s Code-to-Earn model (And why you should too)October 23, 2024 | msn.comFinland's largest energy company files €800 million lawsuit against RussiaOctober 22, 2024 | msn.comFirebrick Pharma’s Strategic Moves Boost Market PositionOctober 22, 2024 | markets.businessinsider.comThis Podiatrist Closed The $30 Million Gap Between Orthopedic And Fashion-Forward FootwearOctober 22, 2024 | forbes.comSee More Headlines FWP Stock Analysis - Frequently Asked Questions How were Forward Pharma A/S's earnings last quarter? Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. What other stocks do shareholders of Forward Pharma A/S own? Based on aggregate information from My MarketBeat watchlists, some other companies that Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Akari Therapeutics (AKTX), Aldeyra Therapeutics (ALDX) and Inovio Pharmaceuticals (INO). Company Calendar Last Earnings9/01/2016Today11/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:FWP CUSIPN/A CIK1604924 Webwww.forward-pharma.com Phone(453) 344-4242FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio18.43 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.09 per share Price / Book0.19Miscellaneous Outstanding Shares7,091,000Free Float2,023,000Market Cap$13.83 million OptionableNot Optionable Beta1.38 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report This page (NASDAQ:FWP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forward Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Forward Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.